Tanya Siddiqi, M.D., is an accomplished hematologist-oncologist who specializes in diagnosing and treating blood cancers, particularly chronic lymphocytic leukemia (CLL) and B-cell non-Hodgkin lymphomas. She is the Medical Director of Lymphoma at City of Hope Orange County and the Director of the CLL Program in the Department of Hematology/HCT. In addition to her clinical practice, Dr. Siddiqi is also the principal investigator of several national and international clinical trials evaluating the role of targeted therapies, including CAR T cell therapy, and other novel agents in diseases like CLL and B-cell non-Hodgkin lymphomas. As a result, she has been part of many major presentations and publications in recent years, some of which have led to FDA approvals of agents and have been practice changing.
Dr. Siddiqi earned her medical degree in 2000 at the Aga Khan University Medical College in Karachi, Pakistan. Afterwards, she completed an internal medicine residency at the University of Connecticut Health Center, followed by two fellowships: Hematology/Oncology at Beth Israel Deaconess Medical Center (Harvard Medical School, Boston, MA) and Hematopoietic Cell Transplantation at City of Hope. At City of Hope, Dr. Siddiqi is a member of the Toni Stephenson Lymphoma Center, the Gehr Family Center for Leukemia Research, and the Immunotherapy Disease Team.